IL-17 mRNA in sputum of asthmatic patients: Linking T cell driven inflammation and granulocytic influx?

Respiratory Research

Volumn 7, Issue , 2006, Pages

  Bullens, Dominique M A ^a,b   Truyen, Els ^a   Coteur, Liesbeth ^a   Dilissen, Ellen ^a   Hellings, Peter W ^a,b   Dupont, Lieven J ^a,b   Ceuppens, Jan L ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b RESEARCH FOUNDATION FLANDERS FWO   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CORTICOSTEROID; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17A; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ALLERGIC ASTHMA; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GRANULOCYTE; HELPER CELL; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MALE; MODERATE PERSISTENT ASTHMA; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEVERE PERSISTENT ASTHMA; SPUTUM ANALYSIS; T LYMPHOCYTE; TH17 CELL; TH2 CELL; ADOLESCENT; AGED; CONTROLLED CLINICAL TRIAL; GENETICS; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; SPUTUM;

ADOLESCENT; ADULT; AGED; ASTHMA; FEMALE; GRANULOCYTES; HUMANS; INTERLEUKIN-17; INTERLEUKIN-8; MALE; MIDDLE AGED; RNA, MESSENGER; SPUTUM; T-LYMPHOCYTES;

EID: 33751180809     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-7-135     Document Type: Article

References (43)

1. Busse WW, Lemanske RF: Asthma. N Engl J Med 2001, 344:350-362.
2. Kay AB: The role of T lymphocytes in asthma. Chem Immunol Allergy 2006, 91:59-75.
3. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al.: Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992, 326:298-304.
4. Wills-Karp M: Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999, 17:255-281.
5. Heijink IH, van Oosterhout AJ: Targeting T cells for asthma. Curr Opin Pharmacol 2005, 5:227-231.
6. Kuipers H, Lambrecht BN: The interplay of dendritic cells, Th2 cells and regulatory T cells in asthma. Curr Opin Immunol 2004, 16:702-708.
7. Hansen G, Berry G, DeKruyff RH, Umetsu DT: Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999, 103:175-183.
8. Cui J, Pazdziorko S, Miyashiro JS, Thakker P, Pelker JW, Declercq C, et al.: TH1-mediated airway hyperresponsiveness independent of neutrophilic inflammation. J Allergy Clin Immunol 2005, 115:309-315.
9. Truyen E, Coteur L, Dilissen E, Overbergh L, Dupont LJ, Ceuppens JL, et al.: Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients. Thorax 2006, 61:202-208.
10. Park H, Li Z, Yang X, Chang SH, Nurieva R, Wang Y-H, et al.: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133-1141.
11. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al.: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123-1132.
12. Kolls JK, Lindén A: Interleukin-17 family members and inflammation. Immunity 2004, 21:467-476.
13. Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Pagé N, et al.: IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001, 108:430-438.
14. Sun Y-c, Zhou Q-t, Yao W-z: Sputum interleukin-17 is increased and associated with airway neutrophilia in patients with severe asthma. Chin Med J 2005, 118:953-956.
15. Barczyk A, Pierzchala W, Sozanska E: Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med 2003, 97:726-733.
16. Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I, et al.: Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002, 17:375-387.
17. Hellings PW, Kasran A, Liu Z, Vandekerckhove P, Wuyts A, Overbergh L, et al.: Interleukin-17 orchestrates the granulocyte influx into airways after allergen challenge inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol 2003, 28:42-50.
18. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ: Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999, 160:1532-1539.
19. Tillie-Leblond I, Gosset P, Tonnel A-B: Review article: Inflammatory events in severe acute asthma. Allergy 2005, 60:23-29.
20. Wenzel S, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, et al.: Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999, 160:1001-1008.
21. Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID: Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002, 57:875-879.
22. Woodruff PG, Khashayar R, Lazarus SC, Janson S, Avila P, Boushey HA, et al.: Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. J Allergy Clin Immunol 2001, 108:753-758.
23. Barnes PJ: Pharmacology of airway smooth muscle. Am J Respir Crit Care Med 1998, 158:S123-S132.
24. Cundall M, Sun Y, C M, Trudeau JB, Barnes S, Wenzel SE: Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids. J Allergy Clin Immunol 2003, 112:1064-1071.
25. Lindén A: Role of interleukin-17 and the neutrophil in asthma. Int Arch Allergy Immunol 2001, 126:179-184.
26. Gibson PG, Simpson JL, Saltos N: Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001, 119:1329-1336.
27. Folkard SG, Westwick J, Millar AB: Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthma. Eur Respir J 1997, 10:2097-2104.
28. Xiao W, Hsu Y-P, Ishizaka A, Kirikae T, Moss RB: Sputum cathelicidin, urokinase plasminogen activation system components and cytokines discriminate cystic fibrosis, COPD and asthma inflammation. Chest 2005, 128:2316-2326.
29. Ordonez CL, Shaughnessy TE, Matthay MA, Fahy JV: Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: clinical and biologic significance. Am J Respir Crit Care Med 2000, 161:1185-1190.
30. Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanovic R, Maestrelli P, et al.: Sputum induction. Eur Respir J 2002, 20(suppl 37):3s-8s.
31. Gelder CM, Thomas PS, Yates DH, Adcock IM, Morrison JF, Barnes PJ: Cytokine expression in normal, atopic, and asthmatic subjects using the combination of sputum induction and the polymerase chain reaction. Thorax 1995, 50:1033-1037.
32. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C: An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001, 25:386-401.
33. Global Initiative for Asthma: Global strategy for Asthma management and Prevention Bethesda (MD): NIH Publication; 2002.
34. Dupont LJ, Rochette F, Demedts MG, Verleden GM: Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Am J Respir Crit Care Med 1998, 157:894-989.
35. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR: Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999, 14:902-907.
36. Pizzichini E, Pizzichini MMM, Efthimiadis A, Hargreave FE, Dolovich J: Measurements of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J 1996, 9:1174-1180.
37. Vanaudenaerde BM, Dupont LJ, Wuyts WA, Verbeken EK, Meyts I, Bullens DM, et al.: The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J 2006, 27:779-787.
38. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ: Increased nitric oxide in exhaled air of asthmatic patients. The Lancet 1994, 343:133-135.
39. Prause O, Laan M, Lötvall J, Lindén A: Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-α- and interleukin-8 release in human bronchial epithelial cells. Eur J Pharmacol 2003, 462:193-198.
40. Rahman MS, Yang J, Shan LY, Unruh H, Yang X, Halayko AJ, et al.: IL-17R activation of human airway smooth muscle cells induces CXCL-8 production via a transcriptional-dependent mechanism. Clin Immunol 2005, 115:268-276.
41. Wenzel S: Severe asthma in adults. Am J Respir Crit Care Med 2005, 172:149-160.
42. Fukakusa M, Bergeron C, Tulic MK, Fiset P-O, Dewachi OA, Laviolette M, et al.: Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-γ-inducible protein-10 expression in asthmatic airway mucosa. J Allergy Clin Immunol 2005, 115:280-286.
43. Cox G: Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol 1995, 154:4719-4725.